date,title,source
Oct-30-18,Mustang Bio Announces Updates on CAR T Cell Therapy Clinical Trials with City of Hope,GlobeNewswire
Nov-01-18,Will Fortress Biotech (FBIO) Report Negative Earnings Next Week? What You Should Know,Zacks
Nov-09-18,"Fortress Biotech (FBIO) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-09-18,Fortress Biotech: 3Q Earnings Snapshot,Associated Press
Nov-09-18,Fortress Biotech Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights,GlobeNewswire
Nov-13-18,InvaGen (a Cipla subsidiary) Announces Acquisition Agreement with Avenue Therapeutics for Specialty Hospital Business in the U.S.,GlobeNewswire
Nov-14-18,"Consolidated Research: 2018 Summary Expectations for Franco-Nevada, CPS Technologies, I.D., Fortress Biotech, Avalon, and Key Tronic  Fundamental Analysis, Key Performance Indications",GlobeNewswire
Nov-19-18,"Fortress Biotech Announces Agreement to Sell Its Majority Stake in National Holdings Corporation to NHC Holdings, LLC, a wholly-owned subsidiary of B. Riley Financial",GlobeNewswire
Nov-19-18,B. Riley Financial Enters Agreement to Purchase Fortress Biotechs Stake in National Holdings,GlobeNewswire
Nov-19-18,B. Riley Financial Enters a Definitive Agreement to Purchase Fortress Biotechs Stake in National Holdings Corporation,GlobeNewswire
Nov-20-18,Fortress Biotech (FBIO) in Focus: Stock Moves 6.5% Higher,Zacks
Dec-12-18,"Should You Worry About Fortress Biotech, Inc.s (NASDAQ:FBIO) CEO Pay?",Simply Wall St.
Dec-19-18,Avenue Therapeutics Announces Dosing of First Patient in Second Pivotal Phase 3 Clinical Trial of Intravenous Tramadol for the Management of Postoperative Pain,GlobeNewswire
Dec-20-18,Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm,GlobeNewswire
Dec-21-18,Fortress Biotech Recaps Corporate Highlights and Achievements in 2018,GlobeNewswire
Jan-02-19,"Report: Exploring Fundamental Drivers Behind Energy Transfer LP, Cable One, DTE Energy, Civitas Solutions, Owens Realty Mortgage, and Fortress Biotech  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Jan-28-19,ATXI: How Much Are CVRs Worth?,Zacks Small Cap Research
Jan-31-19,4 Biotech Stocks Making Moves On Thursday (1/31/19),ACCESSWIRE
Jan-31-19,Fortress Biotech Announces CAEL-101 Strategic Partnership with Alexion Pharmaceuticals,GlobeNewswire
Feb-01-19,"Fortress BioTech, Late Stage Development Progress and Caelum Partnership with Alexion",ACCESSWIRE
Feb-01-19,Biotechs to Put on Your Watchlist,ACCESSWIRE
Feb-05-19,Biotech on the Brink of Breaking Out,ACCESSWIRE
Feb-11-19,Avenue Therapeutics Announces First Stage Closing of its Acquisition Agreement with InvaGen (a Cipla subsidiary),GlobeNewswire
Feb-12-19,Fortress Biotech Completes Final Stage Closing of the Sale of its Remaining Shares of National Holdings Corporation,GlobeNewswire
Feb-20-19,Mustang Bio and Nationwide Childrens Hospital Enter into Exclusive Worldwide License Agreement for Oncolytic Virus (C134) to Treat Glioblastoma Multiforme,GlobeNewswire
Feb-28-19,Sarepta (SRPT) Jumps: Stock Rises 8.3%,Zacks
Mar-12-19,Avenue Therapeutics Reports Full Year 2018 Financial Results and Recent Corporate Highlights,GlobeNewswire
Mar-13-19,Mustang Bio to Present at Oppenheimers 29th Annual Healthcare Conference,GlobeNewswire
Mar-14-19,All You Need to Know About Fortress Biotech (FBIO) Rating Upgrade to Strong Buy,Zacks
Mar-18-19,Mustang Bio Reports Full-Year 2018 Financial Results and Recent Corporate Highlights,GlobeNewswire
Mar-18-19,Fortress Biotech Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent Corporate Highlights,GlobeNewswire
Apr-01-19,Mustang Bio Announces $20 Million Venture Debt Financing Agreement with Horizon Technology Finance,GlobeNewswire
Apr-09-19,Mustang Bio to Present at the World Orphan Drug Congress USA 2019,GlobeNewswire
Apr-17-19,Mustang Bio Soars 485% After Its Novel Gene Therapy Cured Bubble Boys,Bloomberg
Apr-17-19,St. Jude Childrens Research Hospital publishes results of Lentiviral Gene Therapy for Treatment of Infants with X-linked Severe Combined Immunodeficiency in New England Journal of Medicine,GlobeNewswire
Apr-18-19,Bubble Boy Biotech Soars 250 Percent After Cure Announcement,Bloomberg
Apr-23-19,Is Mustang Bio the Next Great Biotech Stock?,InvestorPlace
Apr-29-19,Mustang Bio Announces Proposed Public Offering of Common Stock,GlobeNewswire
Apr-29-19,"What Kind Of Shareholders Own Fortress Biotech, Inc. (NASDAQ:FBIO)?",Simply Wall St.
Apr-30-19,Avenue Therapeutics Announces Appointment of Dr. Thomas G. Moore to Board of Directors,GlobeNewswire
May-01-19,Checkpoint Therapeutics Announces Positive Interim Clinical Results of Anti-PD-L1 Antibody Cosibelimab,GlobeNewswire
May-08-19,Mustang Bio Announces Full Exercise of Option,GlobeNewswire
May-08-19,Mustang Bio Announces City of Hope Opens First-of-Its-Kind Multiple Myeloma CAR T Cell Therapy Trial Targeting CS1 Protein,GlobeNewswire
May-09-19,Checkpoint Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights,GlobeNewswire
May-10-19,Fortress Biotech: 1Q Earnings Snapshot,Associated Press
May-10-19,Fortress Biotech Reports First Quarter 2019 Financial Results and Recent Corporate Highlights,GlobeNewswire
May-13-19,Mustang Bio to Present at the Cell & Gene Therapy USA Congress 2019,GlobeNewswire
May-13-19,Avenue Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights,GlobeNewswire
May-16-19,Mustang Bio and Nationwide Childrens Hospital Receive Orphan Drug Designation for MB-108 (Oncolytic Virus C134) for the Treatment of Malignant Glioma,GlobeNewswire
May-17-19,Will Fortress Biotech to Surge Higher?,Zacks
